Replies to post #39576 on NorthWest Biotherapeutics Inc (NWBO)

[Dan88]

I want to use my last post as I am a paid subscriber in this board to say that the only thing I can come up now to explain the low share price now is of a conspiracy one which may be just an entertaining:

Since no other major funds have paid attention to the company except for those which have already had a major position, when news like this (always fuzzy or not transparent or straightforward due to its nature) broke out, not many funds really understand what it really means; on the other hand, the shorts funds have always thought in a biased way just as the long funds have always thought in an equally biased way in different direction, short funds have continually shorted shares they can have to subdue the price, hoping one day the company will go bankrupt, while the long funds already in major positions don't want to take a bit of more risk, decided to sit it out for a definite sign.

So there is still a depressed price.

The good thing if God willing, is that if that definite sign is out, both longs and short funds and the general public and lots of new funds will compete with ever dwindling share counts, and the price will go much much higher than if the price now were in the teens or twenties!

[sentiment_stocks]

Dan,

To be clear, are you thinking if AA is in process, and a patient was cleared tomorrow from the pipeline as not being pseudo or rapid, they wouldn't be randomized into the trial and begin treatment and/or placebo?

It's only screening that's been halted, not enrollment. Enrollment would mean those patients that clear the pipeline enter the trial. I'd think that wouldn't stop. Otherwise, wouldn't they have halted "enrollment" as well as "screening"?

Why stop the randomization process with only a screening halt?